Bioenergy Life Science, Minneapolis, MN, has granted exclusive North American distribution rights of Corvalen D-Ribose to Douglas Laboratories, Pittsburgh, PA, for the healthcare practitioner market. The body uses ribose to regulate synthesis of adenosine triphosphate (ATP), which is the energy currency of cells. Corvalen contains a patented formulation of pure Bioenergy Ribose.